The updated vaccines are approved for people 12 and older and are authorized under emergency use for individuals 6 months through 11 years old. are eligible to receive this season's COVID-19 vaccine, even if they have never been vaccinated against COVID-19 before," Albert Bourla, chairman and chief executive officer at Pfizer, said in a news release. Now, most people 6 months or older in the U.S. Overall, the new FDA decision "comes at a time when COVID-19 cases are once again climbing. So there is a substantial level of population immunity already."
"Right now we have the vast majority of the population with vaccine immunity, natural immunity, or both. I don't think we're going to have a surge at the level that we saw a year or two years ago, but where it will peak I think remains to be seen," he said. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who was not involved in developing either the Moderna or Pfizer vaccines but previously helped study the Johnson & Johnson vaccine.įor the approaching fall and winter, "the trajectory of where we're going is difficult to tell. However, the overall uptick is small relative to recent season peaks.Īs for Covid-19, "at the present time, we are seeing an uptick in infection rates as well as hospitalizations, however, the absolute rates of severe disease, hospitalizations, and death are still very low compared with where we were a year ago and two years ago," said Dr. RSV cases are also beginning to slightly increase in parts of the West and Midwest, according to the CDC. The CDC has already warned that RSV levels are starting to pick up in the South, doubling between late July and late August. We very much encourage those who are eligible to consider getting vaccinated."Įxperts have expressed concerns about the impacts the triple threat of viral illnesses will have this fall. "The public can be assured that these updated vaccines have met the agency's rigorous scientific standards for safety, effectiveness, and manufacturing quality.
Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a news release Monday. "Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death," Dr. They're debuting amid a late summer rise in COVID-19 hospitalizations in the United States and growing concerns about the effects that the triple threat of respiratory viruses - coronavirus, flu and respiratory syncytial virus - may have this fall and winter season. Health officials are urging people to get vaccinated as soon as the shots are available. The advisory group is scheduled to meet to discuss COVID-19 vaccines Tuesday, meaning the vaccines could become available within just a few days at certain pharmacies and doctor's offices. After the CDC director signs off on those recommendations, the vaccines can be administered. The Advisory Committee on Immunization Practices, a group of independent experts that advises the US Centers for Disease Control and Prevention on its vaccination decisions, will now weigh the safety and effectiveness of the updated vaccines and make recommendations for their use. WASHINGTON - The US Food and Drug Administration gave the green light Monday to updated COVID-19 vaccines from Moderna and Pfizer/BioNTech amid rising cases and hospitalizations.īoth vaccine manufacturers have said testing shows that their vaccines are effective against EG.5, the currently dominant strain in the United States. The FDA signed off on new COVID vaccine boosters that target the XBB.1.5 Omicron subvariant and EG.5.
0 kommentar(er)
